Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,299
Closed -$17K 2079
2025
Q3
$17K Buy
+1,299
New +$19.3K ﹤0.01% 1298
2025
Q2
Sell
-371
Closed -$8K 1901
2025
Q1
$8K Buy
+371
New +$7.69K ﹤0.01% 1210
2024
Q3
Sell
-503
Closed -$12K 1748
2024
Q2
$12K Buy
+503
New +$25.1K ﹤0.01% 1111
2023
Q2
Sell
-73
Closed -$12K 1892
2023
Q1
$12K Buy
73
+12
+20% +$2.53K ﹤0.01% 1329
2022
Q4
$13K Buy
+61
New +$23K ﹤0.01% 1343
2022
Q3
Sell
-62
Closed -$26K 2106
2022
Q2
$26K Buy
+62
New +$30K ﹤0.01% 1278
2022
Q1
Sell
-25
Closed -$28K 1892
2021
Q4
$28K Buy
+25
New +$54.3K ﹤0.01% 1461
2021
Q3
Sell
-123
Closed -$355K 1841
2021
Q2
$355K Buy
+123
New +$291K 0.03% 631
2021
Q1
Sell
-142
Closed -$136K 1909
2020
Q4
$136K Buy
142
+107
+306% +$91.5K 0.01% 977
2020
Q3
$28K Sell
35
-12
-26% -$10.7K ﹤0.01% 893
2020
Q2
$45K Buy
+47
New +$47K 0.01% 1019
2019
Q4
$25K Buy
+46
New +$19.2K ﹤0.01% 1294
2018
Q4
Sell
-30
Closed -$17K 1875
2018
Q3
$17K Buy
+30
New +$18.3K ﹤0.01% 1422

Other funds holding PAVM

Virtu Financial's PAVM Position: Q4 2025 in Review

Virtu Financial sold out of PAVmed (PAVM) in Q4 2025, closing a stake of 1,299 shares — an estimated $17K sold.

Virtu Financial first reported a position in PAVM in Q3 2018 and held it in 13 quarters. The position peaked at $355K in Q2 2021. 28 funds tracked by Wall St. Rank hold PAVM as of Q4 2025.

  • Virtu Financial reported no remaining PAVmed position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 1,299 PAVmed shares in Q4 2025, an estimated $17K.
  • Virtu Financial first reported a position in PAVmed in Q3 2018 and held it in 13 quarters.
  • Virtu Financial's PAVmed position peaked at $355K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held PAVmed as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.